Announcements Trials

Browse Landscape

Phase

Phase NA 2 Phase 1/2 2 Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 6 Multiple Myeloma 5 Prostatic Neoplasms 4 Neoplasm Metastasis 4 Myelodysplastic Syndromes 4 Lung Neoplasms 4 Breast Neoplasms 4 Carcinoma, Non-Small-Cell Lung 3 Triple Negative Breast Neoplasms 2 Stomach Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Mycosis Fungoides 2 Lymphoma, T-Cell 2 Lymphoma, Large-Cell, Anaplastic 2 Lymphoma, B-Cell 2 Leukemia, Biphenotypic, Acute 2 Glioma 2 Colorectal Neoplasms 2 Osteosarcoma 1 Opioid-Related Disorders 1 Neurofibrosarcoma 1 Neurofibromatosis 1 1 Neuroblastoma 1 Neoplasms 1 Melanoma 1 Medulloblastoma 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell, Cutaneous 1

Interventions

pembrolizumab 92 Nivolumab 56 Ipilimumab 55 Cyclophosphamide 52 Vemurafenib 28 fludarabine 27 aldesleukin 25 Interleukin-2 25 fludarabine phosphate 21 trametinib 20 dabrafenib 17 Temozolomide 14 Biopsy 14 Cisplatin 13 spartalizumab 12 atezolizumab 12 Carboplatin 11 cobimetinib 10 Paclitaxel 10 Introns 10 CTLA-4 Antigen 10 poly ICLC 9 binimetinib 9 Specimen Handling 9 Radiotherapy 9 Radiosurgery 9 MART-1 Antigen 9 tremelimumab 8 incomplete Freund's adjuvant 8 Radiation 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Melanoma × X-Rays × Clear all

NCT01295931 2015-10-07

Nuclear and Near-Infrared (NIR) Imaging in Melanoma

M.D. Anderson Cancer Center

Phase 1 Completed

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡